{"disease":{"id":"plasmodium-vivax-malaria","name":"plasmodium vivax malaria"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05052502","title":"Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand","phase":"NA","overall_status":"UNKNOWN","enrollment_count":49118,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04416945","title":"Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic","phase":"NA","overall_status":"UNKNOWN","enrollment_count":31443,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05690841","title":"FocaL Mass Drug Administration for Vivax Malaria Elimination","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":7530,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06575647","title":"Vivax Elimination With Tafenoquine (VET) Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1242,"lead_sponsor_name":"Shoklo Malaria Research Unit","has_results":false},{"nct_id":"NCT04411836","title":"Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":960,"lead_sponsor_name":"Menzies School of Health Research","has_results":false},{"nct_id":"NCT02001428","title":"Malaria in Early Life Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":757,"lead_sponsor_name":"Gadjah Mada University","has_results":false},{"nct_id":"NCT04704999","title":"Southeast Asia Dose Optimization of Tafenoquine","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":700,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT05788094","title":"ACT vs CQ With Tafenoquine for P. Vivax Mono-infection","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":606,"lead_sponsor_name":"Shoklo Malaria Research Unit","has_results":false},{"nct_id":"NCT00138489","title":"Papua New Guinean Duffy Negativity And Vivax Malar","phase":"","overall_status":"TERMINATED","enrollment_count":266,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT07373301","title":"Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":72,"lead_sponsor_name":"Malaria Vaccine and Drug Development Center","has_results":false},{"nct_id":"NCT05380388","title":"A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 )","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":36,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT00295581","title":"PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":0,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}